Anyone have a guess as to what we hear when Sirtris announces early SRT501 effects on cancer in September?
(At least 60 Minutes said that was when early results would be in)
Dramatic effect on most cancers?
Dramatic effect on one or two, but little effect on others?
An overall disappointment?
Other?
I'm also curious why the trials are with SRT501 and not also a small experimental group with SRT2104.
The site shows SRT2104 going into phase I trials later this year. You'd think there would be cancer patients willing
to try SRT2104 today, although maybe they can't until the phase I trials are over.
Edited by Holmes, 02 July 2009 - 12:36 AM.
